PROTEOMICS - Clinical Applications has developed into a key source of information in the field of applying proteomics to the study of human disease and translation to the clinic. With 12 issues per year, the journal will publish papers in all relevant areas including:

• basic proteomic research designed to further understand the molecular mechanisms underlying dysfunction in human disease
• the results of proteomic studies dedicated to the discovery and validation of diagnostic and prognostic disease biomarkers
• the use of proteomics for the discovery of novel drug targets
• the application of proteomics in the drug development pipeline
• the use of proteomics as a component of clinical trials.

New for PCA in 2010!

• Newly structured abstracts including a "CLINICAL RELEVANCE" subject box.
• New manuscript type "Standardization & Guidelines". These articles describe recommendations or best practices on all aspects of proteomics, from experiment planning to data availability.
• • Revised instructions to Authors now available in HTML format under http://forauthors.clinical.proteomics-journal.com
• New Senior Editor - Visith Thongboonkerd (Bangkok, Thailand)
• New members of the Editorial Board raise the clinical profile of the journal: Alan Everett (Baltimore, MD, USA), Peter Liu (Toronto, Canada), Andre Terzic (Rochester, MN, USA).

Upcoming special issues in 2010

• Reviews 2010
• Liver Proteomics
• Cancer Proteomics
• Translating Proteomics to Clinical Practise